Latest news and research on all cancers and treatments, updated several times a week
New Biomarkers in Prostate Cancer
In this article, we review recent advances in the discovery of prostate cancer biomarkers, their integration into clinical practice, and implications for improving clinical management of the disease.
In this article, we review recent advances in the discovery of prostate cancer biomarkers, their integration into clinical practice, and implications for improving clinical management of the disease.
Treatment of Metastatic Pancreatic Adenocarcinoma: A Review
Gemcitabine monotherapy has been the standard of care for patients with metastatic pancreatic cancer for several decades. Despite recent advances in various chemotherapeutic regimens and in the development of targeted therapies, metastatic pancreatic cancer remains highly resistant to chemotherapy.
Gemcitabine monotherapy has been the standard of care for patients with metastatic pancreatic cancer for several decades. Despite recent advances in various chemotherapeutic regimens and in the development of targeted therapies, metastatic pancreatic cancer remains highly resistant to chemotherapy.
Appropriate Management of Molecular Subtypes of Diffuse Large B-Cell Lymphoma
The classification of diffuse large B-cell lymphoma into three distinct molecular diseases--germinal center B-cell-like subtype, an activated B-cell-like subtype, and a primary mediastinal B-cell lymphoma subtype--has laid the foundation for the development of new agents and novel strategies that target individual subtypes.
The classification of diffuse large B-cell lymphoma into three distinct molecular diseases--germinal center B-cell-like subtype, an activated B-cell-like subtype, and a primary mediastinal B-cell lymphoma subtype--has laid the foundation for the development of new agents and novel strategies that target individual subtypes.
Updates on the Management of Breast Cancer Brain Metastases
In this overview, we will review recent developments in the management of breast cancer brain metastases and current prospective trials of systemic therapies specifically for patients with breast cancer brain metastases, with a focus on novel pathway-specific therapies.
In this overview, we will review recent developments in the management of breast cancer brain metastases and current prospective trials of systemic therapies specifically for patients with breast cancer brain metastases, with a focus on novel pathway-specific therapies.
Heterogeneity and Cancer
Cancer heterogeneity, long recognized as an important clinical determinant of patient outcomes, was poorly understood at a molecular level. Genomic studies have significantly improved our understanding of heterogeneity, and have pointed to ways in which heterogeneity might be understood and defeated for therapeutic effect.
Cancer heterogeneity, long recognized as an important clinical determinant of patient outcomes, was poorly understood at a molecular level. Genomic studies have significantly improved our understanding of heterogeneity, and have pointed to ways in which heterogeneity might be understood and defeated for therapeutic effect.
“We have long wondered whether the immune system itself could be harnessed to fight breast cancercells. As we have learned more about how the ...
However, very very tiny amounts of the mineral selenium can stop the cancer-induced 'over-stimulation' of the immune system, helping it return to it's ...
Owing to its absence in humans, the body's immune system treats it as a foreign object ... Studies in the past have linked grilled red meat with cancer.
Every three weeks, she receives an infusion of a drug called keytruda, which stimulates the patient's own immune system to fight the cancer. "Miracle ...
For the first time in more than 50 years, doctors have found a way to treat this dreadful disease — by using the capabilities of our own immune system.
The research team investigated if using the Vaccinia oncolytic virus (a modified virus that specifically kills cancer cells) for the treatment of pancreatic ...
Pancreatic cancer cells seen through a scanning electron micrograph. Researchers at Johns Hopkins have found that tissues such as these have a ...
Tambahkan Komentar